MAPT and Alzheimer disease: The association between cognitive measures and [18-F]AV1451 PET tau is widely established in AD studies (43–45); however, the relationship between cognition and [18-F]AV1451 PET tau among the PSP and CBS cases is usually described as poor (45, 46).